US biotech Moderna (Nasdaq: MRNA) today announced that in consultation with the US Food and Drug Administration (FDA), the ...

Anglo-Swedish pharma major AstraZeneca reports that it will have a historic presence at this year’s American Society of ...

Earlier this month, the US Department of Health and Human Services (HHS) said it would require all future vaccines to undergo ...

Founded in 2021 by Joe Betts-LaCroix and initially funded with $180 million from OpenAI CEO Sam Altman, Retro aims to extend ...

The Dementia Discovery Fund (DDF)—managed by healthcare fund manager SV Health Investors—has announced the final closing of ...

Pharmasyntez, one of Russia’s leading drugmakers, plans a significant expansion of its portfolio of innovative drugs in the ...

US biotechs Protagenic Therapeutics (Nasdaq: PTIX) and Phytanix Bio have entered into a definitive share exchange agreement ...

North Carolina, USA-based vTv Therapeutics (Nasdaq: VTVT) has announced that screening has been reinitiated in the company’s ...

Swiss reproductive and women’s health medicines specialist ReproNovo today announced the successful closing of a $65 million ...

UK-based Juvenescence, a clinical stage AI-enabled biotech company, has secured a total of $76 million in the first-close of ...

US biotech company SparX Biopharmaceutical has signed a research agreement with Mitsubishi Tanabe Pharma America aimed at ...

German antibody drug conjugate (ADC) specialist Tubulis announced that the first program from its 2023 licensing accord with ...